Profund Advisors LLC

SEC CIK: 0001129919
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 10,444
Value: $6.51M
% of portfolio: 0.2%
Quarters held: 22; Since Q1 2021

Holdings of REGN by Profund Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	10,444	$6.51M	0.2%	+112+1.1%	Added	Holders
Q1 2026	10,332	$7.98M	0.3%	−2,328−18.4%	Reduced	Holders
Q4 2025	12,660	$9.77M	0.3%	+825+7.0%	Added	Holders
Q3 2025	11,835	$6.65M	0.2%	−1,078−8.3%	Reduced	Holders
Q2 2025	12,913	$6.78M	0.2%	+1,388+12.0%	Added	Holders
Q1 2025	11,525	$7.31M	0.3%	−1,253−9.8%	Reduced	Holders
Q4 2024	12,778	$9.10M	0.3%	+1,075+9.2%	Added	Holders
Q3 2024	11,703	$12.3M	0.5%	−966−7.6%	Reduced	Holders
Q2 2024	12,669	$13.3M	0.5%	+1,663+15.1%	Added	Holders
Q1 2024	11,006	$10.6M	0.4%	−683−5.8%	Reduced	Holders
Q4 2023	11,689	$10.3M	0.4%	+1,523+15.0%	Added	Holders
Q3 2023	10,166	$8.37M	0.5%	+1,689+19.9%	Added	Holders
Q2 2023	8,477	$6.09M	0.3%	+691+8.9%	Added	Holders
Q1 2023	7,786	$6.40M	0.4%	−9,430−54.8%	Reduced	Holders
Q4 2022	17,216	$12.4M	0.8%	−65−0.4%	Reduced	Holders
Q3 2022	17,281	$11.9M	0.9%	−1,022−5.6%	Reduced	Holders
Q2 2022	18,303	$10.8M	0.7%	−2,059−10.1%	Reduced	Holders
Q1 2022	20,362	$14.2M	0.6%	−4,130−16.9%	Reduced	Holders
Q4 2021	24,492	$15.5M	0.5%	−2,742−10.1%	Reduced	Holders
Q3 2021	27,234	$16.5M	0.6%	+61+0.2%	Added	Holders
Q2 2021	27,173	$15.2M	0.5%	−932−3.3%	Reduced	Holders
Q1 2021	28,105	$13.3M	0.5%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.